‹ All stocks

Kalaris Therapeutics Inc

KLRS · NASDAQ · Healthcare

$2.80

▲ $2.80 (2.94%)

1D 7D 1M 3M 1Y All

Day range

$2.62 – $2.84

Year range

$2.50 – $11.88

Open

$2.72

Previous close

—

Market cap

$61.12M

Volume (24h)

$2.1K

Volume (52w)

$5.80K

Performance

▼ -1.75%

▼ -22.87%

▼ -42.03%

▼ -55.84%

▼ -65.13%

YTD

▼ -66.27%

▼ -99.73%

▼ -99.98%

All-time

▼ -99.98%

Key statistics

P/E ratio

-1.39

EPS (TTM)

$-2.02

Dividend yield

—

Dividend (TTM)

—

Payout ratio

—

Shares outstanding

21.8M

About Kalaris Therapeutics Inc

Kalaris Therapeutics Inc. operates as a pharmaceutical enterprise. The company's core mission centers on developing innovative cell therapies. These treatments are designed to reactivate the body's inherent immunity against critical, virus-linked diseases, especially in patients with profoundly compromised immune systems.

Visit website

Country: United States of America

LLY Eli Lilly and Company	$1156.42	0.49%
JNJ Johnson & Johnson	$254.52	-0.58%
ABBV AbbVie	$262.04	0.29%
MRK Merck & Co.	$139.70	-2.76%
UNH UnitedHealth Group Incorp…	$371.61	-0.19%